Certara Inc

Stock Chart, Company Information, and Scan Results

$11.55(as of Oct 30, 11:26 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Certara Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$11.55
Ticker SymbolCERT
ExchangeNasdaq
SectorHealthcare
IndustryHealth Information Services
Employees1,487
CountyUSA
Market Cap$1,948.4M
EBIDTA104.7M
10-Day Moving Average12.33
P/E Ratio233.48
20-Day Moving Average12.51
Forward P/E Ratio27.17
50-Day Moving Average11.75
Earnings per Share0.05
200-Day Moving Average11.75
Profit Margin-1.88%
RSI43.22
Shares Outstanding160.6M
ATR0.59
52-Week High15.69
Volume1,583,042
52-Week Low8.64
Most Recent Support Level12.03
Book Value1,070.6M
Most Recent Resistance Level12.94
P/B Ratio1.74
Upper Keltner13.83
P/S Ratio4.59
Lower Keltner11.19
Debt-to-Equity Ratio13.83
Next Earnings Date11/05/2025
Cash Surplus31.8M
Next Ex-Dividend DateUnknown

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines; Chemaxon Compound Registration, that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Certara Inc In Our Stock Scanner

As of Oct 30, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.